Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease
Advanced Materials · 2026-03 · 38 (17)
DOI: 10.1002/adma.202523005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 17.02.2026. Verfasst von Han Gao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, Southeast University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: RNA Interference, Myocardial Ischemia, Nanomedicine, RNAi Therapeutics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fellowship of China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Ischemic heart disease (IHD) remains the foremost cause of mortality worldwide, characterized by extensive myocardial injury following infarction with limited regenerative capacity of the adult mammalian heart. RNA interference (RNAi) nanotechnology is revolutionizing cardiac therapy by leveraging the sequence‐oriented gene regulation that can overcome the obstacles hindering conventional therapeutic approaches. Here, we outline the evolving landscape of RNAi nanomedicine for cardiac repair, with an emphasis on therapeutic advances in myocardial infarction and atherosclerosis. We further discuss design considerations for constructing effective nanosystems, underscoring the critical principles by bridging mechanistic insights with material engineering. Finally, we delineate the translational pathway from bench to bedside, detailing current challenges and highlighting prospective opportunities for advancing RNAi therapeutics in cardiovascular therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
- Department of Nutrition and Food Hygiene, School of Public Health, Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Southeast University, Nanjing, Jiangsu, China.
- Department of Biomaterials and Biomedical Technology, The Personalized Medicine Research Institute (PRECISION), University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands.
ORCID-Profile: Hélder A Santos
Förderung
- National Natural Science Foundation of China
- Fellowship of China Postdoctoral Science Foundation
Zitieren
APA
Gao, H., Pan, D., & Santos, H. A. (2026). Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease. Advanced Materials, 38(17). https://doi.org/10.1002/adma.202523005
Vancouver
Gao H, Pan D, Santos HA. Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease. Advanced Materials. 2026;38(17). doi:10.1002/adma.202523005
BibTeX
@article{Gao2026,
author = {Gao, Han and Pan, Da and Santos, Hélder A},
title = {Advancing the Landscape of RNAi Nanotherapeutics for Ischemic Heart Disease},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {17},
doi = {10.1002/adma.202523005}
}
EUVIMED